Sexual-biased necroinflammation is revealed as a predictor of bevacizumab benefit in glioblastoma.

Autor: Hiller-Vallina, Sara, Mondejar-Ruescas, Lucia, Caamaño-Moreno, Marta, Cómitre-Mariano, Blanca, Alcivar-López, Denisse, Sepulveda, Juan M, Hernández-Laín, Aurelio, Pérez-Núñez, Ángel, Segura-Collar, Berta, Gargini, Ricardo
Zdroj: Neuro-Oncology; Jul2024, Vol. 26 Issue 7, p1213-1227, 15p
Databáze: Complementary Index